Research Article
Effect of Glucose or Fat Challenge on Aspirin Resistance in Diabetes
Table 1
Baseline measures.
| Patient characteristic | Diabetics () |
| Gender (M/F) | 28/28 | ASA dose (81 mg/325 mg) | 48/8 | Prior CVD | 8/58 (14%) | Smoking, (%) | 7/49 (14%) | Age (years) | | BMI (kg/m2) | | Medication (%) | | ACE inhibitors or ARB | 36% | Statin | 51% | Insulin | 43% | Waist circumference (cm) | | Systolic BP (mmHg) | | Diastolic BP (mmHg) | | 11-dh-TxB2 (pg/mg creatinine) | | ASA-S (%) | 64% | VerifyNow (ARU) | | ASA-S (%) | 82% | LDL (mg/dL) | | HDL (mg/dL) | | TG (mg/dL) | | Creatinine (mg/dL) | | HbA1c % | | Fasting Glucose (mg/dL) | | Duration of diabetes (years) | |
|
|
Values are presented in means ± SE. 11-dh-TxB2: Urine thromboxane, ARU: Aspirin resistance units, TG: Triglyceride, LDL: Low density lipoproteins, HDL: High density lipoprotein, ASA-S: Aspirin sensitive, ARB: Angiotensin receptor blocker, ACE: Angiotensin converting enzyme.
|